A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Goldman Sachs predicts 1% boost in US GDP if 60 million Americans take GLP-1 weight loss drugs by 2028, noting poor health impacts economic growth through missed days at work, early death, and informal caregiving that takes people out of the workforce

Morgan Stanley: Eli Lilly may become first biopharma firm to hit US$1T valuation with help of orally administered GLP-1 drug Orforglipron, whose phase 3 trial results are due in 2025; Lilly now offers injectable Tirzepatide under Mounjaro, Zepbound labels

FDA approves Novartis and Genentech's Xolair, the first and only medicine for children and adults with one or more food allergies; over 40% of children, more than half of adults with food allergies have experienced a severe reaction at least once

Biogen receives European Commission approval for Skyclarys omaveloxolone, the first therapy to treat Friedreich’s Ataxia, a rare, genetic, progressive neurodegenerative disease; Skyclarys is an oral, once-daily medication

FTC and HHS to investigate pharmaceutical chain middlemen's business practices possibly contributing to drug shortages; seek stakeholder input on market concentration and contracting methods, with a decision due in mid-April

Ask us about our Logistic & Supply Chain market view

Trending Chart

Interactive chart with headline count